News / Korea / yonhap_finance
Key Corporate Filings for KOSPI and KOSDAQ: HD Hyundai Oilbank, Samsung Biologics, and More
yonhap_finance · 2026-09-10
019570, 200670, 204270, 205500, 267250, 307180
A summary of major corporate filings from the Korean market on the 10th, covering significant investments, new contracts, and regulatory actions.
What Happened
Corporate Investments and Acquisitions: HD Hyundai Oilbank has expanded its stake in H&L Advanced with a 600 billion KRW investment. Additionally, IL acquired an 80% stake in Lead Engineering for 12.8 billion KRW to bolster its business portfolio.
Contracts and Capital Raising: Samsung Biologics secured a major contract worth 350.8 billion KRW with a European firm, signaling continued growth in order volume. Meanwhile, Nexuss and GMI Venture both announced third-party capital increases to secure operational funding.
Shareholder Returns and Subsidiaries: Humedix announced the cancellation of treasury shares valued at 5 billion KRW to enhance shareholder value. JNTC received a capital injection of 53.9 billion KRW from its parent company, J&TC, to support its operational needs.
Regulatory Developments: The Korea Fair Trade Commission has launched investigations into 18 companies, including construction firms, for failing to pay subcontracting fees on time. This move highlights the regulator's ongoing efforts to enforce fair trade practices across the industry.